Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2022 | Career development in SCT and cellular therapy for young physicians

Valentín Ortiz-Maldonado • 22 Mar 2022
EBMT 2022
General

Valentín Ortiz-Maldonado, MD, Hospital Clínic de Barcelona, Barcelona, Spain, summarizes the recommendations on career paths in the cellular therapy field that were discussed at EBMT. Young physicians from many countries shared their experiences with initiating their careers and the difficulties encountered, along with the key step of choosing a mentor. Proactivity in pushing projects forward is highly regarded and mentors’ trust is usually not gained overnight. Hard work and the strength to overcome adversities are good signs of future success. This interview took place at the 48th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2022, which was held virtually.

Disclosures

Research grants: Fundación Española de Hematología y Hemoterapia
Travel grants: Kite, Celgene, Novartis, Roche, Takeda & Janssen
Consultant or advisory fees: Kite, Celgene-BMS, Novartis & Janssen
Honoraria: Kite
Employment: Hospital Clínic, Barcelona

More from Valentín Ortiz-Maldonado

The future of CAR T-cell therapy for B-ALL: multi-infusion strategies, MRD-guided approaches & more
1:49
The future of CAR T-cell therapy for B-ALL: multi-infusion strategies, MRD-guided approaches & more
Valentín Ortiz-Maldonado • 17 Feb 2026
Results of the Phase II CART19-BE-02 trial of var-cel (ARI-0001) in patients with R/R B-ALL
2:44
Results of the Phase II CART19-BE-02 trial of var-cel (ARI-0001) in patients with R/R B-ALL
Valentín Ortiz-Maldonado • 17 Feb 2026
The current status of CAR T-cell therapy in adult B-ALL: comparing approved constructs
2:44
The current status of CAR T-cell therapy in adult B-ALL: comparing approved constructs
Valentín Ortiz-Maldonado • 17 Feb 2026
A
3:34
A "dose-dense" approach to CAR-T administration in a trial investigating JCAR014 in B-cell lymphoma
Valentín Ortiz-Maldonado • 7 Feb 2025

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI for clinical decision-making
2:25
Addressing the risk of over-reliance on AI for clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals